These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34464903)

  • 1. Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection.
    Sánchez-Calvo JM; Alados Arboledas JC; Ros Vidal L; de Francisco JL; López Prieto MD
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115491. PubMed ID: 34464903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.
    Wollschläger P; Todt D; Gerlitz N; Pfaender S; Bollinger T; Sing A; Dangel A; Ackermann N; Korn K; Ensser A; Steinmann E; Buhl M; Steinmann J
    Clin Microbiol Infect; 2021 Sep; 27(9):1353.e1-1353.e5. PubMed ID: 34044153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay.
    Giovacchini N; Coppi M; Aiezza N; Baccani I; Malentacchi F; Pollini S; Antonelli A; Rossolini GM
    Int J Infect Dis; 2021 Dec; 113():207-209. PubMed ID: 34628023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial N-gene target failure in the Seegene Allplex SARS-CoV-2 Master Assay as a proxy of SARS-CoV-2 BA.2.86.
    Valli MB; Schiavone ML; Rueca M; Berno G; Spezia PG; Gruber CEM; Forbici F; Fabeni L; Focosi D; Girardi E; Meledandri M; Maggi F
    Microbiol Spectr; 2024 Jun; 12(6):e0017924. PubMed ID: 38647335
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework.
    Chung PYJ; Dhillon SK; Simoens C; Cuypers L; Laenen L; Bonde J; Corbisier P; Buttinger G; Cocuzza CE; Van Gucht S; Van Ranst M; Arbyn M
    Microbiol Spectr; 2024 Feb; 12(2):e0239723. PubMed ID: 38189291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Laverack M; Tallmadge RL; Venugopalan R; Cronk B; Zhang X; Rauh R; Saunders A; Nelson WM; Plocharczyk E; Diel DG
    Arch Virol; 2021 Sep; 166(9):2551-2561. PubMed ID: 34259914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance.
    Zelyas N; Pabbaraju K; Croxen MA; Lynch T; Buss E; Murphy SA; Shokoples S; Wong A; Kanji JN; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0031521. PubMed ID: 34378966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of SARS-CoV-2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays.
    Sit BHM; Po KHL; Cheung YY; Tsang AKL; Leung PKL; Zheng J; Lam AYT; Lam ETK; Ng KHL; Chan RCW
    J Clin Virol Plus; 2022 Aug; 2(3):100091. PubMed ID: 35761832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A straightforward molecular strategy to retrospectively investigate the spread of SARS-CoV-2 VOC202012/01 B.1.1.7 variant.
    Ibba G; Sau R; Angioj F; Abbondio M; Rubino S; Uzzau S
    J Infect Dev Ctries; 2021 Mar; 15(2):242-246. PubMed ID: 33690207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.
    Abdulnoor M; Eshaghi A; Perusini SJ; Broukhanski G; Corbeil A; Cronin K; Fittipaldi N; Forbes JD; Guthrie JL; Kus JV; Li Y; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Sullivan A; Tran V; Patel SN; Allen VG; Gubbay JB
    Microbiol Spectr; 2022 Feb; 10(1):e0068121. PubMed ID: 35170989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three molecular diagnostic assays for SARS-CoV-2 detection: Evaluation of analytical sensitivity and clinical performance.
    Kim HN; Yoon SY; Lim CS; Yoon J
    J Clin Lab Anal; 2022 Feb; 36(2):e24242. PubMed ID: 35019184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Point Mutations in the N Gene of SARS-CoV-2 Adversely Impact Detection by a Commercial Dual Target Diagnostic Assay.
    Miller S; Lee T; Merritt A; Pryce T; Levy A; Speers D
    Microbiol Spectr; 2021 Dec; 9(3):e0149421. PubMed ID: 34787486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time.
    Blairon L; Piteüs S; Beukinga I; Tré-Hardy M
    J Med Virol; 2021 Apr; 93(4):2538-2542. PubMed ID: 33415765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR.
    Amato L; Jurisic L; Puglia I; Di Lollo V; Curini V; Torzi G; Di Girolamo A; Mangone I; Mancinelli A; Decaro N; Calistri P; Di Giallonardo F; Lorusso A; D'Alterio N
    Emerg Microbes Infect; 2021 Dec; 10(1):1148-1155. PubMed ID: 34019466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?
    Farfour E; Lesprit P; Visseaux B; Pascreau T; Jolly E; Houhou N; Mazaux L; Asso-Bonnet M; Vasse M;
    Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):1997-2000. PubMed ID: 32462501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.
    Bal A; Destras G; Gaymard A; Stefic K; Marlet J; Eymieux S; Regue H; Semanas Q; d'Aubarede C; Billaud G; Laurent F; Gonzalez C; Mekki Y; Valette M; Bouscambert M; Gaudy-Graffin C; Lina B; Morfin F; Josset L;
    Euro Surveill; 2021 Jan; 26(3):. PubMed ID: 33478625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cycle Threshold Probability Score for Immediate and Sensitive Detection of B.1.351 SARS-CoV-2 Lineage.
    De Smet D; Vanhee M; Maes B; Swaerts K; De Jaeger P; Maelegheer K; Van Hoecke F; Martens GA
    Am J Clin Pathol; 2022 May; 157(5):731-741. PubMed ID: 34724038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR.
    Abdel Sater F; Younes M; Nassar H; Nguewa P; Hamze K
    Mol Biol Rep; 2021 Nov; 48(11):7243-7249. PubMed ID: 34613565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.